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Abstract
Background:  Pancreatic cancer is a biologically aggressive disease with less than 20% of patients
suitable for a "curative" surgical resection. This, combined with the poor 5-year survival indicates
that effective palliative methods for symptom relief are required. Currently there are no ablative
techniques to treat pancreatic cancer in clinical use. Tissue electrolysis is the delivery of a direct
current between an anode and cathode to induce localised necrosis. Electrolysis has been shown
to be safe and reliable in producing hepatic tissue and tumour ablation in animal models and in a
limited number of patients. This study investigates the feasibility of using electrolysis to produce
localised pancreatic necrosis in a healthy rat model.
Method:  Ten rats were studied in total. Eight rats were treated with variable "doses" of coulombs,
and the systemic and local effects were assessed; 2 rats were used as controls.
Results:  Seven rats tolerated the procedure well without morbidity or mortality, and one died
immediately post procedure. One control rat died on induction of anaesthesia. Serum amylase and
glucose were not significantly affected.
Conclusion:  Electrolysis in the rat pancreas produced localised necrosis and appears both safe,
and reproducible. This novel technique could offer significant advantages for patients with
unresectable pancreatic tumours. The next stage of the study is to assess pancreatic electrolysis in
a pig model, prior to human pilot studies.
Introduction
Pancreatic cancer is biologically aggressive and the ma-
jority of patients present with advanced disease. Radical
surgical resection of the pancreas offers the only hope of
cure but only 20% of tumours in the head and 3% of tu-
mours elsewhere in the pancreas are suitable for curative
resection [1–3]. Many other patients undergo a trial dis-
section before a palliative surgical procedure is carried
out. Locally advanced tumours that involve major blood
vessels and metastatic disease are the most common fac-
tors that preclude curative resection. Therefore, the
mainstay of treatment at present is palliative, directed
towards relieving obstructive jaundice, gastric outlet ob-
struction and pain.
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Electrolysis is a simple technique using a direct current
passed through a conductive medium between a pair of
electrodes, measured in Coulombs (1 Coulomb = 1 am-
pere ×  1 second).Tissue electrolysis produces chemicals
at the electrodes [4–6] and the ensuing pH change caus-
es a localised parenchymal necrosis [7]. During the past
few years, electrolysis of liver tumours has been exten-
sively investigated at this institution [8–12]. Not only has
the process been shown to completely ablate liver tu-
mours in animal models [11] and in humans [13]. It is
also safe and predictable in terms of both its inherent tis-
sue destruction and the inability to thrombose or breach
large blood vessels in close proximity to the electrolysis
[12]. Electrolytic ablation of pancreatic tumours is an en-
tirely novel idea, both for the treatment of pancreatic
cancer and for the use of electrolysis. The aim of this
study was to assess whether electrolysis of the pancreas
gland could be performed in a safe and reproducible
manner.
Method
The experiment was approved by the ethics committees
of the University of Adelaide and The Queen Elizabeth
Hospital. The Direct Current (DC) generator (Bioengi-
neering, Transducers and Signal Processing Research
Group, University of Leicester, United Kingdom) was de-
signed to deliver a preset dose of Coulombs, using a con-
tinuous current (8 mA) at a variable voltage depending
on resistance of the tissue, in accordance with Ohms law
(V = IR). The anode and cathode were made from fine
platinum wires 0.5 mm in diameter. These were insulat-
ed from each other at the proximal end by a semi-rigid
plastic sleeve.
Ten SPF female Sprague-Dawley rats were fasted over-
night. They were weighed pre-procedure, and anaesthe-
tised using a standard mixture of halothane, nitrous
oxide and oxygen. The rats were induced in a perspex box
with 3.5% halothane, 1 L/min nitrous oxide and 1 L/min
oxygen. Maintenance of anaesthesia was achieved with
an inhalation system using 1.5% halothane, 0.5 L/min of
nitrous oxide and 0.3 L/min oxygen.
The pancreas was exposed through a midline laparoto-
my. Swabs were placed around the pancreas to protect
the surrounding organs. Two platinum electrodes desig-
nated anode and cathode, were inserted into the pancre-
as at a depth of 2 mm and a separation of 1 mm. A
variable dose of Coulombs was delivered, ranging from 0
to 10 Coulombs (Table 1). The control rat underwent the
same procedure, but without the delivery of current. Se-
rial blood samples were obtained from the tail vein, pre-
operatively then at 1, 4, 24 and 48 hours post-operatively
and analysed for amylase and glucose. All rats were sac-
rificed at 72 hours, weighed and the pancreata removed.
This tissue was then fixed in 10% buffered formalin for a
minimum of 2 weeks to allow for sufficient fixation. The
area of pancreas that had been electrolytically treated
was then embedded in paraffin, sectioned and stained
with haematoxylin and eosin for histological examina-
tion. Electrolytic lesions were graded by a histopatholo-
gist who was unaware of the Coulombs administered.
The lesions were graded according to the scoring system
described by Spormann et al [14], to obtain a comparable
histological score (Table 2).
Table 1: Dose of Coulombs delivered to rats
Dose Of Coulombs Number Of Rats Deaths
(mA/sec)
0 (control) 2 1+
21
41
62
82
10 2 1*
+ During anaesthetic induction * Under anaesthetic on completion of 
electrolysis
Table 2: Histological scoring of pancreatitis
Oedema
1 = Mild
2 = Moderate
3 = Severe
Inflammatory Infiltrate
1 = Mild
2 = Moderate
3 = Severe
Fat Necrosis
3 = Mild
5 = Moderate
7 = Severe
Parenchymal Necrosis
3 = Singular
5 = Sub lobular <1/3
7 = Lobular >1/3
Haemorrhage
3 = Mild
5 = Moderate
7 = Severe
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Results
Median pre-procedure weight of the rats was 250 gm,
(range 242–257 gm). There was no weight loss in any of
the rats prior to tissue harvesting.
Of the 2 control rats, one animal died on induction of an-
aesthetic before any procedure had been performed, and
the other tolerated the laparotomy and sham procedure
without any side effects. In the treatment group, eight
rats received between 2 to 10 Coulombs. One rat died im-
mediately post electrolysis whilst under general anaes-
thetic. Seven rats survived with no morbidity or
mortality. All eight animals that survived appeared clin-
ically well, and were all eating and drinking within 2
hours of the procedure. On dissection of the pancreas
gland an area of necrosis was evident on all the treated
organs.
Blood results
The control group showed no significant change in amy-
lase concentration (Figure 1). The treatment group re-
vealed a transient hyperamylasaemia, peaking at
approximately 4 hours which was not dose related and
was not statistically significant.
Glucose levels were essentially unchanged in the control
and treatment rats over the period of investigation (Fig-
ure 2).
Histology
On harvesting, a localised necrotic electrolytic lesion was
macroscopically visible in all specimens of the pancreas
(Figure 3), with no evidence of bowel perforations, fluid
collections or haemorrhage. The necrotic lesion itself
was difficult to measure due to the mucinous nature of
the rat pancreas gland. The ablated region was surround-
ed by discoloured pancreatic tissue. There was a small
area of inflammation (brown in colour) around the
necrotic region, which was graded using the histological
score, this was not proportional to the electrolytic dose
(Figure 4). The inflammation did not extend through the
pancreas.
Discussion
Pancreatic carcinoma has a poor prognosis, and involve-
ment of major blood vessels and metastatic disease are
the most common factors that preclude curative resec-
tion [1,15]. Therefore, the mainstay of treatment at
present is palliative, and there has been little advance-
ment in new palliative treatments in the last few decades.
Symptoms requiring palliation include anorexia, nausea,
vomiting, weight loss and epigastric and back pain
[15,16]. Nausea and vomiting are due to mechanical and
Figure 1
Serum amylase plotted against time (in hours) Figure 2
Serum glucose levels plotted against time (in hours)
Figure 3
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functional impairment of gastric and duodenal empty-
ing. Pain results from malignant involvement of the
splanchnic plexus, or from obstruction to the pancreatic
duct. Biliary obstruction may cause jaundice often asso-
ciated with intractable pruritus. Most symptoms are pro-
gressive and reflect locally advanced disease at
presentation. A proportion of patients undergo attempt-
ed resection but at the time of operation the presence of
local and/or distant disease, and invasion of the major
vessels, prevents any surgical resection, and palliation is
resorted to. Surgical palliation consists of biliary, and or
gastric bypass,and an increasing number of patients are
undergoing this form of treatment [17]. Palliation is also
possible by endoscopic stenting of the obstructed com-
mon bile duct [18]. The ideal palliation would include the
relief of pain, jaundice and gastro-duodenal obstruction,
to improve quality of life measures with minimum mor-
bidity. Local tumour destruction by electrolysis may not
affect the overall tumour biology but may ameliorate the
mass effect of the tumour, decrease tumour burden and
destroy afferent nerves and could be performed at the
time of biliary by-pass.
There are several ablative techniques that are currently
being investigated and employed mainly for liver tu-
mours. Several of these techniques rely on a direct ther-
mal insult to cause local tissue ablation. These include
interstitial laser therapy [19], radiofrequency ablation
[20], and cryotherapy [21]. Thermal ablative techniques
have limitations, particularly related to cytokine release
in "cryoshock phenomenon"[22,23] and charring in the
heat methods [24]. Pancreatic cryotherapy has been re-
ported in a single study, but the data reported was inad-
equate to make any conclusions [25]. A recent report of
radiofrequency ablation in the porcine pancreas has
shown this to be feasible and safe [26].
Electrolysis has the potential to be adapted for pancreat-
ic tissue ablation. A direct current is passed through a
conductive medium between a pair of electrodes. Plati-
num electrodes appear ideal as they are relatively inert,
but also have potential anti-neoplastic properties in the
formation of platinum salts [27–29]. Tissue electrolysis
produces sodium hydroxide and hydrogen at the cathode
(alkaline), and hydrochloric acid and chlorine gas at the
anode (acidic) [4–6]. The significant pH changes pro-
duced by electrolysis are cytotoxic and cause localised
tissue necrosis [7]. Electrolytic ablation does not rely on
a thermal effect [8,30].
The hypothesis of this study was that electrolytic de-
struction of the pancreas would result in a localised pan-
creatitis. The extent and severity of this was assessed in
the experiment using blood and histological analysis.
In caerulein-induced pancreatitis in rats serial serum
amylase has shown a 2 to 5 fold increase from the control
value [31]. The hyperamylasemia with a proportion of
the animals in this study (at approximately 4 hours) was
not statistically significant in a paired T-test comparing
the pre-electrolytic samples, with the 4 hour samples
(Sig 2-tailed = 0.72).
Serum glucose would be expected to rise in severe pan-
creatitis according to Ranson's criteria [32] but this was
not demonstrated in this study where it was relatively
unchanged throughout all the animals.
The histology of the sections was quantified using a point
score originally described by Spormann et al [14]. Elec-
trolysis of the pancreas gland produced a region of
necrosis. There was a localised region of pancreatitis
around the electrolysis site, but this was not throughout
the gland. It shows there is a generalised increase in the
cumulative score although this was not dose related and
was not significantly different from the control value.
The dismal outcome of pancreatic cancer and the need
for low morbidity palliation has prompted the investiga-
tion of electrolysis as a possible method of palliation by
tumour ablation. This study has demonstrated that elec-
trolysis in the rat pancreas produce localised necrosis
that appears both safe and reproducible. This pilot study
was performed in only a small number of animals, but all
animal deaths were believed to be related to the anaes-
thesia. All the rats that survived recovered well following
electrolysis. The study indicates that localised pancreatic
ablation is feasible with electrolysis. There was a local-
ised region of pancreatitis around the site of necrosis, but
there were no systemic complications of electrolysis in
this model. The next stage is to extensively investigate
pancreatic electrolysis in a large animal model, to assess
the short and long-term effects, prior to human pilot
Figure 4
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studies. In the larger animal model, a larger volume of
tissue can be ablated with higher doses of Coulombs.
Previous studies have shown that dose of Coulombs de-
livered is proportional to the volume of necrosis pro-
duced [9]. This study investigated the effects of
electrolytic ablation in healthy pancreatic tissue, as this
would have a greater tendency to become inflamed than
that of tumour and thus cause a pancreatitis. A future
area of study could investigate the effect of electrolysis in
rodent pancreatic tumour model [33–36]. This study
was performed on the minium number of animals as a pi-
lot study to show feasibility, but obviously the technique
needs to be performed on a greater number of large ani-
mal models whose pancreatic anatomy is more similar to
that of humans. This novel technique could offer signifi-
cant advantages for patients with unresectable pancreat-
ic tumours.
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